XML 16 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Unaudited) - 6 months ended Jun. 30, 2018 - USD ($)
Series B Convertible Preferred Stock [Member]
Additional Paid-in Capital [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Balance, beginning at Dec. 31, 2017     $ 477,342 $ 71,887,674 $ (65,426,329) $ 6,938,687
Balance, beginning (in shares) at Dec. 31, 2017     2,651,952     2,651,952
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of Series B convertible preferred stock and warrants, net of issuance costs of $1,333,449 $ 14 $ 6,926,778   5,363,759   $ 12,290,551
Issuance of Series B convertible preferred stock and warrants, net of issuance costs of $1,333,449 (in shares) 13,624          
Allocation of Series B convertible preferred stock to beneficial conversion feature   (4,782,100)   4,782,100    
Deemed Dividend on Series B convertible preferred stock   11,479,308   (11,479,308)    
Conversion of Series B convertible preferred stock to common stock $ (8) (7,821,992) $ 399,987 7,422,013    
Conversion of Series B convertible preferred stock to common stock (in shares) (7,822)   2,222,147      
Amortization of commitment shares       (39,703)   (39,703)
Compensation cost for stock options granted to executives and employees       394,189   394,189
Net loss         (6,016,959) (6,016,959)
Balance, ending at Jun. 30, 2018 $ 6 $ 5,801,994 $ 877,329 $ 78,330,724 $ (71,443,288) $ 13,566,765
Balance, ending (in shares) at Jun. 30, 2018 5,802   4,874,099     4,874,099